|
|
||||||||
Basel Institute for Immunology, Basel, Switzerland
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
5 and VpreB proteins (8, 9, 10). Until recently, it was
generally assumed that all H chain proteins were capable of bringing
about these changes; however, a newly defined class of H chains, termed
dysfunctional, neither mediates allelic exclusion nor drives
clonal maturation (11, 12, 13, 14, 15). The underlying mechanism for
this failure is the inability of a dysfunctional H chain protein to
pair with the SLC and form a pBCR (11, 12, 14).
Significantly, failure to pair with SLC is also indicative of the
inability of the H chain protein to pair with conventional L chain
(13). Analysis of the Ig rearrangements from early B cells has revealed that as many as 50% of all H chain proteins are dysfunctional (11, 12). Since single VH genes have been found that can encode for either a functional or a dysfunctional H chain the inability to pair with the SLC must arise as a result of differences within the complementarity-determining region 3 (CDR3) sequence. The CDR3, formed by DNA recombination between VH, D, and JH genes, is the only sequence that varies between H chains using the same VH gene.
H chains using the VH81X gene, a member of the VH7183 gene family, appear to be particularly prone to producing dysfunctional H chain proteins (15). In one series of experiments in which H chain rearrangements isolated from 6- to 8-wk-old mice were screened for their ability to pair with the SLC, all VH81X H chain proteins tested were dysfunctional, whereas all H chains using other members of VH7183 gene family were functional (12). One explanation for these observations is that only an extremely limited spectrum of CDR3 sequences in combination with the VH81X-encoded protein can form a functional H chain. Supporting this concept, the only known functional VH81X H chain isolated to date was derived from fetal liver and, hence, was generated before the onset of TdT expression that generally occurs 23 days after birth (16) (S. Gilfillan, unpublished observation). This is relevant, because TdT adds nontemplated nucleotides (N nucleotides) at the junctions generated during D to JH and VH to DJH rearrangements; therefore, mice expressing TdT have greater CDR3 sequence diversity than mice lacking TdT (17, 18, 19, 20). This extra diversity does not seem particularly beneficial for VH81X expression, as productive VH81X rearrangements are disfavored in adult mice that express TdT and in the livers of fetal mice that express a TdT transgene prematurely during ontogeny (21, 22, 23, 24, 25, 26, 27, 28, 29).
In this study we tried to identify an overall sequence motif that defines a functional H chain. We began our studies by examining VH81X rearrangements, since the a priori expectation would be that the CDR3 sequence diversity of these H chains would be the most severely limited. In fact, given the findings reported to date, it is unclear whether any functional VH81X H chains are generated in mice expressing TdT (11, 12). Previous studies of functional H chains relied on an in vitro assay to identify functional H chains; individual productively rearranged H chain genes were transfected into cell lines expressing the SLC, and those able to promote cell surface expression of the pBCR were scored as positive (11, 12, 14). This was necessary because dysfunctional H chains fail to allelically exclude, so individual B cells can harbor two productive H chain rearrangements, one functional the other dysfunctional (11, 12). Therefore, amplification of H chain rearrangements from surface Ig-positive (sIg+) cells does not guarantee that all productive rearrangements isolated are functional. We have adopted an alternative approach for isolating a pool of functional H chain genes. By crossing mice incapable of producing a H chain molecule (JH knockout) with C57BL/6 mice, we generated offspring hemizygous for H chain rearrangements (30). In these mice all VHDJH rearrangements isolated from sIg+ B cells must be functional. We found that functional VH81X H chains do exist in mice that express TdT and consequently have extensive N region addition. Surprisingly, we found no obvious restrictions on the diversity of CDR3 in these functional VH81X H chains.
| Materials and Methods |
|---|
|
|
|---|
Mice used in these studies were derived by crossing C57BL/6 (BRL, Fullinsdorf, Switzerland) with homozygous JHT knockout mice that had been backcrossed six times onto the C57BL/6 background (The Jackson Laboratory, Bar Harbor, ME) and maintained at the animal facility at Basel Institute for Immunology (Basel, Switzerland). The derived F1 mice were sacrificed either at 68 wk of age or for neonatal studies 23 days after birth.
Isolation and staining of whole bone marrow
Whole bone marrow cells were isolated by flushing the femurs and tibias with HBSS (Life Technologies, Grand Island, NY) supplemented with 0.1% BSA (fraction V; Sigma-Aldrich, St. Louis, MO) and 0.1% sodium azide (HBA). The cells were then passed through Nytex gauze and pelleted by centrifugation at 300 x g for 8 min, followed by resuspension in HBA, counted, and brought to a cell density of 1 x 107/ml. Cells were then stained with anti-IgD-FITC (clone 11-26c.2a; BD PharMingen, San Diego, CA). After a 15-min incubation on ice, excess Ab was removed by washing the cells with HBA. The cells were resuspended in HBA and stained with anti-IgMb PE (clone Af6-78; BD PharMingen). After a final wash, the cell suspension was passed through Nytex gauze and sorted using a MoFlo (Cytomation, Fort Collins, CO) high speed sorter.
Isolation and staining of splenocytes for FACS
A single-cell suspension was derived by carefully homogenizing removed pooled spleens from two 6- to 8-wk-old mice (adult) or at least nine spleens from 2- to 3-day-old neonates. Spleens from adult mice were treated with 0.16 M ammonium chloride, 0.17 M Tris-Cl, pH 7.2, to remove RBC. The splenocytes were resuspended in HBA and stained with either anti-IgD-FITC (clone 11-26c.2a; BD PharMingen) or anti-IgM-Cy5 (Chemicon, Temecula, CA) and anti-B220-FITC (clone RA3-6B2; BD PharMingen, San Diego, CA), incubated, and washed as described above. Adult splenocytes were then stained with anti-IgMb-PE (clone Af6-78; BD PharMingen), incubated for 15 min on ice, and washed to remove excess Ab. Propidium iodine was added to the neonatal splenocytes for live/dead cell discrimination immediately before cell sorting. The cells were then sorted using a MoFlo (Cytomation) high speed sorter.
Genomic DNA preparation and PCR amplification
Genomic DNA was prepared from the sorted cell populations using a Qiagen Blood and Cell Culture DNA Mini kit (Qiagen, Basel, Switzerland) following the manufacturers instructions for the isolation of genomic DNA from cultured cells. The isolated genomic DNA was quantified by optical absorbance. Two hundred nanograms of this genomic DNA was then used as the starting template for the first round of nested PCR with the initial reaction consisting of 5 µl 10x Taq buffer, 2.5 mM MgCl2, 2.5 ng VH-specific primer 1 (see below), 2.5 ng. JH universal primer, 2.5 U Taq polymerase (Roche, Basel, Switzerland), and H2O to a total volume of 50 µl. The reactions were placed into a Biometra thermal cycler (Tampa, FL) and subjected to 10 min at 95oC, followed by 30 cycles of 94oC for 1 min, 50°C for 1 min, and 72°C for 1.5 min. The resultant products were then extended by a 10-min incubation at 72°C, followed by a 4°C soak. Two microliters of this first reaction was used as the template for the second round of PCR. This reaction was conducted as described above with the following exceptions: VH-specific primer 1 was replaced by VH-specific primer 2, one of four JH-specific primers was used instead of the JH universal primer, and the thermal cycling consisted of 10 min at 95°C, 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min, and an extension of products with a 10 -min incubation at 72°C, followed by a 4°C soak. Therefore, four independent second-round PCR amplifications were conducted to isolate VHDJH rearrangements using each JH individually. Upon completion of this second round of PCR, the resultant products were cloned using the TOPO-TA Cloning kit (Invitrogen, San Diego, CA) following the manufacturers instructions. For PCR amplification of products used for expression/pairing analyses, the following modifications to the above protocol were applied: in the first round of amplification each JH-specific primer was used in combination with VH-specific primer 1 in four independent reactions and subjected to thermal cycling consisted of 10 min at 95°C, 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 1.5 min, and an extension of the products with a 10-min incubation at 72°C, followed by a 4°C soak. In a second round of amplification 2 µl of each of the first-round reactions were used as templates using VH-specific primer 2 along with each appropriate JH-specific expression cloning oligonucleotide primer with thermal cycling consisting of 95°C for 10 min, 50°C for 1 min, and 72°C for 30 s, and an extension of the products with a 10-min incubation at 72°C, followed by a 4°C soak.
Preparation of plasmid DNA and sequencing
Plasmid DNA was isolated from 2 ml of the O/N culture using a QIAprep Spin Mini Prep kit (Qiagen). Plasmid DNA positive for PCR inserts, as determined by EcoRI digestion resolved by agarose gel electrophoresis, were used as templates for DNA sequencing using ABI Big Dye Terminator Cycle Sequencing kit (PE Applied Biosystems, Warrington, U.K.) and run on a ABI model 377 automated sequencer following manufacturers instructions. All sequences were read up to the EcoRI site in the VH81X gene. Only sequences with complete identity with the published VH81X gene were included in these analyses.
Sequences of oligonucleotide primers used for PCR
The primer sequences were: VH-specific primer 1, 81X ggaggcttagtgcagcctagagag; VH-specific primer 2, 81X tccctgaggcgcgcctgtgaatcc (nucleotides exchanged from germline sequence are shown in bold forming a unique AscI site (underlined); appropriate for the cloning of PCR products but not used in this current study); JH universal, gaaaactccataacaaagg; JH-specific: JH1, agcttctgcagcatgcagagtgtg; JH2, ggccaggatccctataaatctctg; JH3, acaaaggggttgaatcttgattcc; JH4, aaaataaagacctggagaggc; JH-specific expression: JH1, aagctttgactctctgaggagacggtgacc; JH2, aagctttgactctctgaggagactgtgaga; JH3, aagctttgactctctgcagagacagtgacc; and JH4, aagctttgactctctgaggagacggtgact.
Cloning, transfection, and detection of cell surface expression of H chains
The pELVC retroviral H chain expression vector contains unique
SalI/HindIII restriction sites introduced as
silent mutations in the coding region of the VH
(amino acids 1, 2, and Cµ 3, 4, respectively) and lacks the intron
between JH and Cµ for the cloning of
VH DJH rearrangements
(12). To make use of this system we digested our cloned
and sequenced VH81XDJH
rearrangements (originally from PCR products generated using our
VH81X- and JH-specific
expression primers) with EcoRI/HindIII and
agarose gel purified the appropriate sized
VH81XDJH band from vector
sequence using QiaexII (Qiagen) following manufacturers instructions.
This fragment was then ligated using the Rapid DNA Ligation kit (Roche,
Mannheim, Germany) to pBS-Hinchi; a pBS vector (Stratagene, San Diego,
CA) containing a complete
VH81XDJH rearrangement with
SalI and HindIII sites (gift from X. C. Kong
and T. Rolink) that had been used previously in expression studies was
also digested with EcoRI/HindIII and purified.
The resultant transformants were picked, isolated by mini-prep DNA, and
screened for the presence of the insert. This DNA was then digested
with SalI/HindIII, and the entire VDJ fragment
was cloned into pELVC. One to 2 µg pELVC DNA (by OD measurement) with
each rearrangement to be tested was then used to individually transfect
the retroviral packaging cell line GPE (gift from U. Grawunder). Cells
(2.5 x 105) were plated into six-well
plates the night before transfection using Lipofectamine Plus reagent
(Invitrogen) following the manufacturers protocol. The cells were
incubated for 5 h in the presence of the DNA-Lipofectamine
complexes before addition of medium with serum. These cells were then
grown overnight, medium was replaced, and 3.5 x
105 38B9 cells (gift from J. Andersson and T.
Rolink) were added. After 24 h of coculture the 38B9 cells were
harvested and were cultured overnight before the addition of 15 µg
puromycin to the culture medium. Sufficient cell numbers for FACS
analysis were obtained after 7 days of selection. For FACS analysis,
transfected 38B9 cells were removed from culture, pelleted by
centrifugation, and resuspended in HBA. The cells were then stained
with anti-IgM-Cy5 (Chemicon, Temecula, CA) for 15 min on ice.
Following this the cells were washed in HBA to remove excess Ab and
then analyzed on a FACSCaliber (BD Biosciences, Mountain View, CA).
Propidium iodine (0.6 µg/sample) was added for live/dead cell
discrimination to each sample individually
1 min before FACS
analysis.
| Results |
|---|
|
|
|---|
We began our studies by isolating DNA from FACS-sorted
sIgM+D- immature bone
marrow B cells (Fig. 1
) from 8-wk-old
(C57BL/6XJHT-/-)F1
mice that, as noted above, can only complete H chain rearrangements on
one allele. This population was chosen because all rearrangements
isolated from sIg+ cells must, by definition, be
functional in these mice. Immature bone marrow B cells from mice of
this age would be expected to undergo DNA recombination at the H chain
locus in the presence of TdT. PCR amplification and sequencing of DNA
isolated from these sIgM+ cells revealed that
functional VH81X rearrangements are produced in
the presence of TdT (Fig. 2
) and, indeed,
have N nucleotides. Although not shown in Fig. 2
, all sequences
included in these analyses were read from the JH
gene through the EcoRI site within the
VH81X gene. Only sequences with complete identity
with the published VH81X gene are depicted. As
would be expected from a highly purified preparation of cells from this
population, no nonproductive rearrangements were detected. Overall,
there appeared to be few, if any, constraints on CDR3 sequence length
or diversity in functional VH81X rearrangements;
every amino acid was accommodated, and no shared motifs or patterns
were obvious (Fig. 2
b). Recently, Marshall et al.
(29) identified a degenerative amino acid consensus
sequence that was found to be prevalent among
VH81X rearrangements from fetal and neonatal
mice. The neonatal consensus sequence was based on their observation
that only a limited range of amino acids occurred at the junction
between the VH81X gene and the selected D gene.
In particular, only histidine was found to occur at position 95, using
the numbering system defined by Kabat (29, 30), with
either one of four residues (glycine, serine, tyrosine, and asparagine)
occurring at positions 9698. Since VH81X
rearrangements isolated from fetal or neonatal mice are generally
productive, it seems plausible that possessing this consensus sequence
may confer a selective advantage, such as the ability to pair with SLC
or L chain (24). It was not determined whether the
consensus sequence correlates with the ability of the
VH81X rearrangements to pair with SLC or L chain.
Alternatively, this sequence may occur more often among
VH81X rearrangements in fetal and neonatal mice
due to a lack of TdT expression and therefore a lack of N region
addition and limited sequence variability of CDR3 (21).
For clarity, we have appended this neonatal consensus sequence to the
amino acid sequences isolated from sIgM+ immature
bone marrow cells shown in Fig. 2
b.
|
|
The neonatal consensus is not enriched for among mature splenic B cells
Previous reports have demonstrated a selective decline of
productive VH81X rearrangements with increasing
developmental state (23, 25, 26, 27, 28). Whereas among immature
bone marrow B cells 15% of VH81X rearrangements
are productive, only 5% of the rearrangements isolated from splenic B
cells using this VH gene were found to be
productive (23, 28). This decline apparently mirrors an
increase in the percentage of VH81X
rearrangements that fit the neonatal consensus sequence
(29). Among VH81X rearrangements
isolated from the splenic B cells of BALB/c mice, 40% were observed to
match the consensus sequence, whereas none of the sequences amplified
from sIgM+ immature bone marrow B cells encoded
this motif. Two possible explanations for these findings are: 1)
VH81X rearrangements with the neonatal consensus
sequence rarely occur in older mice that express TdT, but when they do
arise they are selected for and greatly enriched among productive
VH81X rearrangements in the spleen; or 2)
long-lived neonatal B cells that would be expected to frequently use
the neonatal consensus may skew the observed repertoire of splenic B
cells overall. In an attempt to address these issues, we isolated
mature sIgM+D+ cells from
the spleens of F1 mice by FACS as shown in Fig. 3
; sequences of
VH81X rearrangements from this population are
shown in Fig. 4
. Contrary to expectation,
we found that the neonatal consensus sequence is not enriched among the
mature splenic B cells from F1 mice. In fact,
there appears to be little difference in the percentage of
VH81X rearrangements with the neonatal consensus
sequence between the immature B cells in the bone marrow and the mature
splenic B cell pool. One explanation for this difference between a
previous report and our own may lie with the relatively small number of
sequences assessed in the earlier work (five productive
VH81X sequences in total) (29).
|
|
We have interpreted our finding that the neonatal consensus
sequence is not enriched among functional VH81X
rearrangements isolated from mice that express TdT to mean that this
sequence is not predictive for the functionality of
VH81X H chains. This conclusion was reached based
on our finding that there appears to be a lack of selection for the
neonatal consensus sequence among VH81X
rearrangements derived from immature and mature B cells of
F1 mice. Given the apparent lack of selection for
the neonatal consensus sequence among functional H chains isolated from
older mice, we were curious to examine whether, in fact, the neonatal
consensus sequence would be enriched for among the splenic B cell
compartment of neonatal F1 mice. For this we
isolated sIgM+B220+ cells
from the spleens of 2- to 3-day-old F1 mice (Fig. 5
). The VH81X
sequences isolated from this cell population are shown in Fig. 6
; among these, 33% matched the neonatal
consensus sequence. This proportion of neonatal consensus
rearrangements is lower than the 59% reported by Marshall et al.
(29) for neonatal spleen and is identical with the 33%
(three of nine) they noted in sequences amplified from µ membrane,
exon-targeted (µT) fetal liver (a TdT-negative environment in which H
chain expression and selection are not possible, which would,
therefore, provide an accurate estimate as to how frequently this
consensus sequence is formed in the absence of TdT and selection).
|
|
Our analyses to date have relied on the supposition that sIg
expression was indicative of the propensity of H chain to interact with
the SLC in forming pBCR. It has been shown that H chains that fail to
interact with SLC also fail to associate with L chain though whether L
chain pairing is indicative of SLC pairing capacity has not been
formally demonstrated (13). To test whether sIg expression
does indeed reflect the propensity of a H chain to pair with SLC, we
made use of a pairing assay first described by ten Boekel et al.
(12). In this system H chains, under transcriptional
control of the Ig promoter and enhancer, are transfected into the 38B9
cell line, which expresses SLC but lacks endogenous H chain expression.
The pairing capacity of the H chain of interest is then scored by
detection of surface H chain expression brought about by pBCR
formation. A representative result obtained from analysis of the
surface pBCR expression of 19 randomly selected
VH81X rearrangements (four isolated from
sIgM+D- adult bone marrow,
eight from adult spleen, and seven from neonatal spleen; for sequences
and whether sIg expression is detected see Figs. 2
b,
4b, and 6b) are shown in Fig. 7
. As a negative control we used a
VH81X rearrangement first described by Jacks
group (13, 14) and shown both in vitro and in vivo to fail
to associate with SLC or form pBCR. We found that the vast majority (16
of 19) of tested rearrangements did, in fact, exhibit some level of
pBCR surface expression. We conclude from these results that the
capacity of a given H chain to associate with SLC can in most instances
be predicted by a given H chains ability to form sIg.
|
| Discussion |
|---|
|
|
|---|
We were unable to elucidate an overall primary structural motif that accounts for H chain (VH81X) functionality. Because this VH gene has an extremely high propensity for encoding dysfunctional H chains, we expected to see obvious structural constraints in functional VH81X H chains within CDR3 (11, 12, 29). Instead, and somewhat surprisingly in light of previous work on this VH gene, we clearly established that structurally diverse functional VH81X H chains can be generated. Applying the opposite experimental approach, looking for a dysfunctional motif, would be even more difficult, since there are no expected limitations on junctional diversity. Although not obvious at this point, the development of computer programs designed to model higher level structural motifs based on sequence data may make it possible to identify a functionality motif among our functional VH81X sequences.
Although we were unable to ascertain an overall functionality motif, we were capable of making a number of novel observations about H chain repertoire selection. Within this study we have demonstrated that the capacity of a H chain to interact with a L chain strongly correlates with a given H chains ability to form pBCR through an interaction with SLC. One role ascribed to the SLC has been to act as a "screener" for the capacity of a newly generated H chain to associate with L chain. If SLC does fill such a role, then it would be expected that the majority of sIg+ cells would, if previously selected by SLC, have the ability to associate with this complex, which is what we have observed.
As stated earlier, VH81X rearrangements are
apparently favored in the neonatal environment, while such
rearrangements generated in the adult are generally disfavored. One
explanation put forward to explain this dichotomy has been that in the
fetal/neonatal environment H chains incapable of associating with SLC
have a growth advantage, while B cells bearing SLC-associating µ are
actively inhibited from continued differentiation; in the adult
environment the converse occurs (32). That is in the adult
environment the capability of a µ-chain to pair with SLC gives that B
cell a growth advantage. In light of this hypothesis, we predicted that
one possible outcome of our surface pBCR assay (Fig. 7
) would be that
very few, if any, of our collection of neonatally derived
VH81X H chains would foster surface pBCR
expression, while nearly all of the adult bone marrow and
spleen-derived H chains would. Contrary to this expectation we found
that regardless of the population the H chain was isolated from that
the majority of H chains tested directed surface pBCR formation. Given
this observation we feel that further studies are needed to address the
differences in selective forces operating within the fetal/neonatal and
adult environments.
In summary we report an efficient system for specifically isolating and analyzing functional H chains. Our VH81X data can easily be augmented to include functional H chains using other VH genes; such analyses may lead to characterization of a prototypic functional H chain structure.
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Gregory H. Kline, Basel Institute for Immunology, Bau 90/519, Basel, CH-4070, Switzerland. E-mail address: kline{at}bii.ch ![]()
3 Abbreviations used in this paper: pBCR, pre-B cell receptor; CDR3, complementarity-determining region 3; sIg, surface Ig; SLC, surrogate L chain. ![]()
Received for publication August 29, 2001. Accepted for publication June 20, 2002.
| References |
|---|
|
|
|---|
5 pre B cell-specific genes can associate with each other and with µ H chain. J. Exp. Med. 172:969.
5 protein in B cell development. Cell 69:823.[Medline]
5 locus of the mouse, which appears to be selectively expressed in pre-B lymphocytes. EMBO J. 6:2267.[Medline]
2 tetramers in pre-B cells by 18K
-immunoglobulin L chain. Nature 329:172.[Medline]
5, a new L chain-related locus selectively expressed in pre-B lymphocytes. Nature 324:579.
5. Ann. NY Acad. Sci. 764:39.[Medline]
This article has been cited by other articles:
![]() |
Y. Kawano, S. Yoshikawa, Y. Minegishi, and H. Karasuyama Pre-B Cell Receptor Assesses the Quality of IgH Chains and Tunes the Pre-B Cell Repertoire by Delivering Differential Signals J. Immunol., August 15, 2006; 177(4): 2242 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawano, S. Yoshikawa, Y. Minegishi, and H. Karasuyama Selection of stereotyped VH81X-{micro}H chains via pre-B cell receptor early in ontogeny and their conservation in adults by marginal zone B cells Int. Immunol., July 1, 2005; 17(7): 857 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Martin, H. Bradl, T. J. Collins, E. Roth, H.-M. Jack, and G. E. Wu Selection of Ig {micro} Heavy Chains by Complementarity-Determining Region 3 Length and Amino Acid Composition J. Immunol., November 1, 2003; 171(9): 4663 - 4671. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |